Bank of Montreal’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-820
| Closed | -$85.6K | – | 3708 |
|
2023
Q1 | $85.6K | Buy |
820
+152
| +23% | +$15.9K | ﹤0.01% | 2997 |
|
2022
Q4 | $119K | Buy |
668
+1
| +0.1% | +$179 | ﹤0.01% | 2893 |
|
2022
Q3 | $127 | Sell |
667
-2
| -0.3% | – | ﹤0.01% | 2935 |
|
2022
Q2 | $86 | Sell |
669
-45,636
| -99% | -$5.87K | ﹤0.01% | 3055 |
|
2022
Q1 | $4.67M | Buy |
+46,305
| New | +$4.67M | ﹤0.01% | 1245 |
|
2021
Q2 | – | Sell |
-60
| Closed | -$24K | – | 4154 |
|
2021
Q1 | $24K | Sell |
60
-270
| -82% | -$108K | ﹤0.01% | 3588 |
|
2020
Q4 | $151K | Buy |
330
+231
| +233% | +$106K | ﹤0.01% | 2919 |
|
2020
Q3 | $46K | Sell |
99
-48
| -33% | -$22.3K | ﹤0.01% | 3075 |
|
2020
Q2 | $83K | Buy |
+147
| New | +$83K | ﹤0.01% | 2822 |
|
2020
Q1 | – | Sell |
-182
| Closed | -$26K | – | 4002 |
|
2019
Q4 | $26K | Buy |
182
+55
| +43% | +$7.86K | ﹤0.01% | 3632 |
|
2019
Q3 | $5K | Buy |
127
+6
| +5% | +$236 | ﹤0.01% | 4049 |
|
2019
Q2 | $12K | Buy |
+121
| New | +$12K | ﹤0.01% | 3971 |
|
2019
Q1 | – | Sell |
-7
| Closed | -$1K | – | 4088 |
|
2018
Q4 | $1K | Buy |
7
+4
| +133% | +$571 | ﹤0.01% | 4175 |
|
2018
Q3 | $1K | Sell |
3
-8
| -73% | -$2.67K | ﹤0.01% | 4232 |
|
2018
Q2 | $5K | Buy |
11
+3
| +38% | +$1.36K | ﹤0.01% | 3791 |
|
2018
Q1 | $3K | Buy |
+8
| New | +$3K | ﹤0.01% | 3713 |
|